Do analysts prefer NYC or MLEC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Strategic Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Moolec Science 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is IVCP or MLEC more profitable?

Moolec Science's return on equity of 0.00% beat Swiftmerge Acquisition's return on equity. Company Net Margins Return on Equity Return on Assets Swiftmerge Acquisition N/A -11.71% -0.23% Moolec Science N/A N/A N/A

Do analysts rate MLEC or MDRR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moolec Science 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Medalist Diversified REIT 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate MLEC or TBMC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moolec Science 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Trailblazer Merger Corporation I 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, MLEC or TBMC?

Trailblazer Merger Corporation I has lower revenue, but higher earnings than Moolec Science. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Moolec Science $333.61M 0.02 -$111.46M -$33.00 N/A Trailblazer Merger Corporation I N/A N/A -$8.29M N/A N/A

Is MLEC or TBMC more profitable?

Company Net Margins Return on Equity Return on Assets Moolec Science N/A N/A N/A Trailblazer Merger Corporation I N/A N/A -37.04%

Do analysts prefer MLEC or ADGM?

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 360.10%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts clearly believe Adagio Medical is more favorable than Moolec Science. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moolec Science 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Is MLEC or ADGM more profitable?

Moolec Science's return on equity of 0.00% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Moolec Science N/A N/A N/A Adagio Medical N/A -382.50% -64.98%

Moolec Science (MLEC) Competitors

$7.63 -0.02 (-0.26%)

Closing price 04:00 PM Eastern

Extended Trading

$7.45 -0.18 (-2.36%)

As of 06:04 PM Eastern

Compare

MLEC vs. NYC, IVCP, MDRR, TBMC, and ADGM

Should you buy Moolec Science stock or one of its competitors? MarketBeat compares Moolec Science with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Moolec Science include American Strategic Investment (NYC), Swiftmerge Acquisition (IVCP), Medalist Diversified REIT (MDRR), Trailblazer Merger Corporation I (TBMC), and Adagio Medical (ADGM). These companies are all part of the "trading" industry.

How does Moolec Science compare to American Strategic Investment?

American Strategic Investment (NYSE:NYC) and Moolec Science (NASDAQ:MLEC) are both small-cap trading companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Strategic Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

48.0% of American Strategic Investment shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 4.0% of American Strategic Investment shares are held by company insiders. Comparatively, 19.9% of Moolec Science shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

American Strategic Investment has a beta of 0.23, meaning that its stock price is 77% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.28, meaning that its stock price is 72% less volatile than the broader market.

In the previous week, American Strategic Investment and American Strategic Investment both had 1 articles in the media. Moolec Science's average media sentiment score of 1.89 beat American Strategic Investment's score of 0.00 indicating that Moolec Science is being referred to more favorably in the news media.

Company	Overall Sentiment
American Strategic Investment	Neutral
Moolec Science	Very Positive

American Strategic Investment has higher earnings, but lower revenue than Moolec Science. American Strategic Investment is trading at a lower price-to-earnings ratio than Moolec Science, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Strategic Investment	$43.28M	0.49	-$21.19M	-$8.45	N/A
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A

Moolec Science has a net margin of 0.00% compared to American Strategic Investment's net margin of -53.18%. Moolec Science's return on equity of 0.00% beat American Strategic Investment's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Strategic Investment	-53.18%	-113.06%	-14.35%
Moolec Science	N/A	N/A	N/A

Summary

Moolec Science beats American Strategic Investment on 8 of the 13 factors compared between the two stocks.

How does Moolec Science compare to Swiftmerge Acquisition?

Swiftmerge Acquisition (NASDAQ:IVCP) and Moolec Science (NASDAQ:MLEC) are both small-cap trading companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

Moolec Science's return on equity of 0.00% beat Swiftmerge Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Swiftmerge Acquisition	N/A	-11.71%	-0.23%
Moolec Science	N/A	N/A	N/A

In the previous week, Swiftmerge Acquisition and Swiftmerge Acquisition both had 1 articles in the media. Moolec Science's average media sentiment score of 1.89 beat Swiftmerge Acquisition's score of 0.00 indicating that Moolec Science is being referred to more favorably in the news media.

Company	Overall Sentiment
Swiftmerge Acquisition	Neutral
Moolec Science	Very Positive

38.1% of Swiftmerge Acquisition shares are held by institutional investors. Comparatively, 0.1% of Moolec Science shares are held by institutional investors. 42.9% of Swiftmerge Acquisition shares are held by insiders. Comparatively, 19.9% of Moolec Science shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Swiftmerge Acquisition has a beta of 0.03, suggesting that its share price is 97% less volatile than the broader market. Comparatively, Moolec Science has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market.

Swiftmerge Acquisition has higher earnings, but lower revenue than Moolec Science. Swiftmerge Acquisition is trading at a lower price-to-earnings ratio than Moolec Science, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Swiftmerge Acquisition	N/A	N/A	$3.42M	-$0.02	N/A
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A

Summary

Moolec Science beats Swiftmerge Acquisition on 6 of the 10 factors compared between the two stocks.

How does Moolec Science compare to Medalist Diversified REIT?

Moolec Science (NASDAQ:MLEC) and Medalist Diversified REIT (NASDAQ:MDRR) are both small-cap trading companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Medalist Diversified REIT	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Medalist Diversified REIT has lower revenue, but higher earnings than Moolec Science. Moolec Science is trading at a lower price-to-earnings ratio than Medalist Diversified REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A
Medalist Diversified REIT	$10.40M	1.72	-$2.39M	$3.75	2.93

Medalist Diversified REIT has a net margin of 74.73% compared to Moolec Science's net margin of 0.00%. Moolec Science's return on equity of 0.00% beat Medalist Diversified REIT's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Moolec Science	N/A	N/A	N/A
Medalist Diversified REIT	74.73%	-16.90%	-6.11%

Moolec Science has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market. Comparatively, Medalist Diversified REIT has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

0.1% of Moolec Science shares are held by institutional investors. Comparatively, 17.4% of Medalist Diversified REIT shares are held by institutional investors. 19.9% of Moolec Science shares are held by insiders. Comparatively, 77.6% of Medalist Diversified REIT shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Medalist Diversified REIT had 1 more articles in the media than Moolec Science. MarketBeat recorded 2 mentions for Medalist Diversified REIT and 1 mentions for Moolec Science. Moolec Science's average media sentiment score of 1.89 beat Medalist Diversified REIT's score of 0.93 indicating that Moolec Science is being referred to more favorably in the media.

Company	Overall Sentiment
Moolec Science	Very Positive
Medalist Diversified REIT	Positive

Summary

Medalist Diversified REIT beats Moolec Science on 10 of the 14 factors compared between the two stocks.

How does Moolec Science compare to Trailblazer Merger Corporation I?

Moolec Science (NASDAQ:MLEC) and Trailblazer Merger Corporation I (NASDAQ:TBMC) are both small-cap trading companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

Trailblazer Merger Corporation I has lower revenue, but higher earnings than Moolec Science.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A
Trailblazer Merger Corporation I	N/A	N/A	-$8.29M	N/A	N/A

Moolec Science has a beta of 0.28, indicating that its share price is 72% less volatile than the broader market. Comparatively, Trailblazer Merger Corporation I has a beta of 0.06, indicating that its share price is 94% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Trailblazer Merger Corporation I	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Moolec Science	N/A	N/A	N/A
Trailblazer Merger Corporation I	N/A	N/A	-37.04%

0.1% of Moolec Science shares are held by institutional investors. Comparatively, 77.1% of Trailblazer Merger Corporation I shares are held by institutional investors. 19.9% of Moolec Science shares are held by company insiders. Comparatively, 86.4% of Trailblazer Merger Corporation I shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Moolec Science had 1 more articles in the media than Trailblazer Merger Corporation I. MarketBeat recorded 1 mentions for Moolec Science and 0 mentions for Trailblazer Merger Corporation I. Moolec Science's average media sentiment score of 1.89 beat Trailblazer Merger Corporation I's score of 0.00 indicating that Moolec Science is being referred to more favorably in the media.

Company	Overall Sentiment
Moolec Science	Very Positive
Trailblazer Merger Corporation I	Neutral

Summary

Moolec Science beats Trailblazer Merger Corporation I on 5 of the 9 factors compared between the two stocks.

How does Moolec Science compare to Adagio Medical?

Moolec Science (NASDAQ:MLEC) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

Moolec Science's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Moolec Science	N/A	N/A	N/A
Adagio Medical	N/A	-382.50%	-64.98%

In the previous week, Adagio Medical had 1 more articles in the media than Moolec Science. MarketBeat recorded 2 mentions for Adagio Medical and 1 mentions for Moolec Science. Moolec Science's average media sentiment score of 1.89 beat Adagio Medical's score of 0.93 indicating that Moolec Science is being referred to more favorably in the media.

Company	Overall Sentiment
Moolec Science	Very Positive
Adagio Medical	Positive

Moolec Science has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.19, meaning that its share price is 119% less volatile than the broader market.

Adagio Medical has lower revenue, but higher earnings than Moolec Science. Adagio Medical is trading at a lower price-to-earnings ratio than Moolec Science, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$333.61M	0.02	-$111.46M	-$33.00	N/A
Adagio Medical	$600K	28.16	-$25.08M	-$1.53	N/A

0.1% of Moolec Science shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 19.9% of Moolec Science shares are owned by company insiders. Comparatively, 7.8% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 360.10%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts clearly believe Adagio Medical is more favorable than Moolec Science.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Adagio Medical beats Moolec Science on 8 of the 15 factors compared between the two stocks.

Get Moolec Science News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLEC vs. The Competition

Export

Metric	Moolec Science	AGRI OPERATIONS Industry	Staples Sector	NASDAQ Exchange
Market Cap	$5.55M	$3.22B	$16.62B	$12.07B
Dividend Yield	N/A	2.77%	3.40%	5.66%
P/E Ratio	-0.23	36.60	26.04	24.57
Price / Sales	0.02	3.61	47.50	141.49
Price / Cash	N/A	8.97	13.38	37.92
Price / Book	-0.02	3.76	5.60	6.78
Net Income	-$111.46M	-$7.12M	$680.43M	$337.32M
7 Day Performance	6.86%	1.90%	2.87%	1.96%
1 Month Performance	-14.56%	-3.63%	3.74%	3.81%
1 Year Performance	-92.50%	-20.34%	-9.71%	32.19%

Moolec Science Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLEC Moolec Science	0.8418 of 5 stars	$7.63 -0.3%	N/A	-92.5%	$5.55M	$333.61M	N/A	4	Positive News Gap Down
NYC American Strategic Investment	0.5104 of 5 stars	$8.59 +1.1%	N/A	-21.1%	$23.11M	$43.28M	N/A	N/A
IVCP Swiftmerge Acquisition	N/A	$3.35 +3.1%	N/A	-64.0%	$22.91M	N/A	N/A	2,021	Gap Down High Trading Volume
MDRR Medalist Diversified REIT	2.9406 of 5 stars	$11.49 +4.8%	N/A	-2.7%	$18.72M	$10.40M	3.06	2,018
TBMC Trailblazer Merger Corporation I	N/A	$7.33 flat	N/A	N/A	$17.96M	N/A	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MLEC) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Moolec Science (MLEC) Competitors

MLEC vs. NYC, IVCP, MDRR, TBMC, and ADGM

How does Moolec Science compare to American Strategic Investment?

Summary

How does Moolec Science compare to Swiftmerge Acquisition?

Summary

How does Moolec Science compare to Medalist Diversified REIT?

Summary

How does Moolec Science compare to Trailblazer Merger Corporation I?

Summary

How does Moolec Science compare to Adagio Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLEC vs. The Competition

Moolec Science Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Moolec Science (MLEC) Competitors

MLEC vs. NYC, IVCP, MDRR, TBMC, and ADGM

How does Moolec Science compare to American Strategic Investment?

Do analysts prefer NYC or MLEC?

Do insiders & institutionals believe in NYC or MLEC?

Which has more volatility and risk, NYC or MLEC?

Does the media refer more to NYC or MLEC?

Which has better valuation and earnings, NYC or MLEC?

Is NYC or MLEC more profitable?

Summary

How does Moolec Science compare to Swiftmerge Acquisition?

Is IVCP or MLEC more profitable?

Does the media refer more to IVCP or MLEC?

Do insiders & institutionals believe in IVCP or MLEC?

Which has more volatility and risk, IVCP or MLEC?

Which has stronger earnings & valuation, IVCP or MLEC?

Summary

How does Moolec Science compare to Medalist Diversified REIT?

Do analysts rate MLEC or MDRR?

Which has preferable earnings & valuation, MLEC or MDRR?

Is MLEC or MDRR more profitable?

Which has more risk and volatility, MLEC or MDRR?

Do insiders & institutionals hold more shares of MLEC or MDRR?

Does the media prefer MLEC or MDRR?

Summary

How does Moolec Science compare to Trailblazer Merger Corporation I?

Which has stronger valuation & earnings, MLEC or TBMC?

Which has more volatility and risk, MLEC or TBMC?

Do analysts rate MLEC or TBMC?

Is MLEC or TBMC more profitable?

Do insiders and institutionals hold more shares of MLEC or TBMC?

Does the media prefer MLEC or TBMC?

Summary

How does Moolec Science compare to Adagio Medical?

Is MLEC or ADGM more profitable?

Does the media favor MLEC or ADGM?

Which has more volatility and risk, MLEC or ADGM?

Which has higher earnings & valuation, MLEC or ADGM?

Do institutionals & insiders hold more shares of MLEC or ADGM?

Do analysts prefer MLEC or ADGM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLEC vs. The Competition

Moolec Science Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools